Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patients with type-2 diabetes

BACKGROUND: Platelet hyperaggregability is a pro-thrombotic feature of type-2 diabetes, associated with low levels of the antioxidant glutathione (GSH). Clinical delivery of N-acetylcysteine (NAC), a biosynthetic precursor of GSH, may help redress a GSH shortfall in platelets, thereby reducing throm...

Descripción completa

Detalles Bibliográficos
Autores principales: Gibson, Kyle R, Winterburn, Tim J, Barrett, Fiona, Sharma, Sushma, MacRury, Sandra M, Megson, Ian L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120650/
https://www.ncbi.nlm.nih.gov/pubmed/21600014
http://dx.doi.org/10.1186/1475-2840-10-43

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120650/
https://www.ncbi.nlm.nih.gov/pubmed/21600014
http://dx.doi.org/10.1186/1475-2840-10-43

Ejemplares similares